SCHEMBL30452976

SCHEMBL30452976

Cc1ccc2cc(-c3cnc(C(=O)O)c(OCc4ccccc4)c3C)ccc2n1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 1/20 0.43
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
MCL1 Q07820 2/20 0.38
STAT3 P40763 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SYK P43405 1/20 0.37
MEN1 O00255 1/20 0.37
HSP90AA1 P07900 1/20 0.37
KMT2A Q03164 1/20 0.37
DHODH Q02127 2/20 0.37
PDE10A Q9Y233 1/20 0.37
VNN1 O95497 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257684 1.00 NPC1 (0.43) NPC1RAB9AKDM4EAKR1C3AKR1C2
Nitrous Acid SCHEMBL29248926 0.97 NPC1 (0.41) NPC1RAB9AKDM4EAKR1C3AKR1C2
SCHEMBL29248955 0.91 PPARG (0.40) NPC1RAB9AKDM4EAKR1C3AKR1C2
SCHEMBL29248922 0.91 NPC1 (0.39) NPC1RAB9AKDM4EAKR1C3AKR1C2
SCHEMBL30546865 0.90 MAOB (0.43) NPC1RAB9AKDM4EAKR1C3AKR1C2
SCHEMBL24257621 0.88 MCL1 (0.44) MCL1MEN1KMT2ADHODH
SCHEMBL30453213 0.88 MCL1 (0.44) MCL1MEN1KMT2ADHODH
Nitrous Acid SCHEMBL29248892 0.88 MAOB (0.41) NPC1RAB9AKDM4EAKR1C3AKR1C2
SCHEMBL24257704 0.85 PPARG (0.39) NPC1RAB9AKDM4EAKR1C3AKR1C2
SCHEMBL30453029 0.85 PPARG (0.39) NPC1RAB9AKDM4EAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670131-A PHD inhibitor compounds, compositions, and methods of use 阿克比治疗有限公司 2023-08-29 CN disclosed
EP-4196466-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2023-06-21 EP disclosed